½É¹æ³ªÆ®·ý¹è¼³ÃËÁø ÆÕƼµå(Atrial Natriuretic Peptide)ÀÇ Hela ¼¼Æ÷ ¼ºÀå ¾ïÁ¦
Atrial Natriuretic Peptide Ingibits the Growth of Hela Cells
¼Ò¼Ó »ó¼¼Á¤º¸
¾çÇѱ¤/Yoshinodu Ohaski
Bruce E/Johnson
KMID : 0360319940260040599
Abstract
º» ¿¬±¸¿¡¼´Â ½É¹æ³ªÆ®·ý¹è¼³ÃËÁø ÆéƼµå(atrial natriuretic peptide: ÀÌÇÏ ANP)¸¦ ¿ÜºÎ¿¡¼ Åõ¿©ÇÏ¿´À» ¶§ HeLa¼¼Æ÷¿¡¼ÀÇ ANP¼ö¿ëüÀÇ 2Â÷ Àü´Þ¹°ÁúÀÎ cGMP ¹×HeLa ¼¼Æ÷ÀÇ ¼ºÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Á¶»çÇÏ¿´´Ù. ´ëÁ¶¼¼Æ÷Áַδ °°Àº »óÇǾϼ¼Æ÷ÁÖÀÎ NCI-N87
¼¼Æ÷ÁÖ¸¦
»ç¿ëÇÏ¿´´Ù.
¼¼Æ÷¿¡¼ÀÇ ANP AÇü ¹× CÇü ¼ö¿ëüÀÇ mRNA ¹ßÇöÀ» º¸±â À§ÇÏ¿© RT-PCR Southern blotting hypridization ºÐ¼®¹ýÀ» ÀÌ¿ëÇÏ¿´°í, ¼¼Æ÷³» cGMP´Â RIA¹ýÀ» ÀÌ¿ëÇÏ¿´´Ù. ¼¼Æ÷ ¼ºÀåÁ¶»ç´Â coulter counter·Î ¼¼Æ÷¼ö¸¦ ¼¼´Â ¹æ¹ý°ú tritiated thymidine incorportation
Á¶»ç¹ýÀ»
ÀÌ¿ëÇÏ¿´´Ù.
HeLa ¼¼Æ÷¿¡¼´Â ANP AÇü ¹×CÇü ¼ö¿ëüÀÇ mRNA¹ßÇöÀÌ ÀÖ¾úÀ¸¸ç, ´ëÁ¶¼¼Æ÷ÁÖÀÎ NCI-N87¿¡¼´Â À̵éÀÇ ¹ßÇöÀÌ ÃøÁ¤µÇÁö ¾Ê¾Ò´Ù. ANP¸¦ 1(10E6¼¼Æ÷¿¡ Åõ¿©ÇÏ¿´À» ¶§ HeLa ¼¼Æ÷¿¡¼´Â ¼¼Æ÷³» cGMP°¡ 0.4 pmole¿¡¼ 9.36 pmole·Î 67¹è Áõ°¡ÇÏ¿´´Ù. ¹Ý¸é
NCI-N87¼¼Æ÷ÁÖ¿¡¼´Â
¼¼Æ÷³» cGMPÀÇ ³óµµ¿¡ º¯È°¡ ¾ø¾ú´Ù. 10¥ìM ANP¸¦ Åõ¿©½Ã 2ÀÏÈÄ HeLa ¼¼Æ÷¿¡ ¼¼Æ÷¼ö´Â ´ëÁ¶±ºº¸´Ù 30% °¨¼ÒÇÏ¿´°í, thymidine incorporationÀÌ 70%°¨¼ÒÇÏ¿´´Ù. ¹Ý¸é, NCI-N87¿¡¼´Â ¼¼Æ÷¼ö³ª thymidine incorporationÀÌ ´ëÁ¶±º°ú Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù.
°á·ÐÀûÀ¸·Î º» ¿¬±¸¿¡¼´Â ´ëÁ¶¼¼Æ÷ÁÖÀÎ NCI-N87¼¼Æ÷¿Í´Â ´Þ¸® Hela¼¼Æ÷¿¡¼ ANP AÇü ¹× CÇü ¼ö¿ëüÀÇ mRNAÀÇ ¹ßÇöÀÌ ÀÖÀ¸¸ç, ANP ¸¦ Åõ¿©½Ã AÇü ¼ö¿ëüÀÇ 2Â÷ Àü´ÞÀÚÀÎ ¼¼Æ÷³» cGMP°¡ Áõ°¡ÇÏ¿´À¸¸ç, ANP°¡ ¼¼Æ÷ÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÔÀ» º¸¿©ÁÖ¾î, ANP°¡ ¾Ï¼¼Æ÷¿¡¼
¼ºÀå¾ïÁ¦ÀÎÀÚ·Î ÀÛ¿ëÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀ» Á¦½ÃÇÏ¿´´Ù.
Å°¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸